| |
Anti-malarial prescribed
|
Antibiotic co-prescription
|
|---|
| |
ART-AQ
|
Other anti-malarial regimen
|
Antibiotic co-prescription
|
No antibiotic
|
|---|
| |
N = 1,217
|
N = 1,614
|
N = 872
|
N = 1,959
|
|---|
| |
n, %
1
|
n, %
|
n, %
|
n, %
|
|---|
|
Gender
|
|
Male
|
464
|
40.9
|
672
|
59.2
|
376
|
33.1
|
760
|
66.9
|
|
Female
|
753
|
44.4
|
942
|
55.6
|
496
|
29.3
|
1,199
|
70.7
|
|
Age group
|
|
<5
|
161
|
26.4
|
449
|
73.6
|
260
|
42.6
|
350
|
57.4
|
|
5–12
|
181
|
56.9
|
136
|
43.1
|
119
|
37.4
|
198
|
62.5
|
|
13–59
|
790
|
46.0
|
926
|
54.0
|
445
|
25.9
|
1, 271
|
74.1
|
|
≥60
|
76
|
48.4
|
81
|
51.6
|
40
|
25.5
|
117
|
74.5
|
|
Not known
|
9
|
29.0
|
22
|
71.0
|
8
|
25.8
|
23
|
74.2
|
|
Facility type
|
|
Non-government
|
15
|
13.0
|
100
|
87.0
|
28
|
24.4
|
87
|
75.7
|
|
Government
|
1,202
|
44.3
|
1,514
|
55.7
|
844
|
31.1
|
1,872
|
68.9
|
|
Mode of diagnosis
|
|
Presumptive
|
1,041
|
42.2
|
1,427
|
57.8
|
758
|
30.7
|
1,710
|
69.3
|
|
Laboratory confirmed
|
79
|
86.8
|
12
|
13.2
|
21
|
23.1
|
70
|
76.9
|
|
Not known
|
97
|
35.7
|
175
|
64.3
|
93
|
34.2
|
179
|
65.8
|
|
Anti-malarial treatment prescribed
|
|
Combination therapy (ART-AQ)
|
-
|
-
|
349
|
28.7
|
868
|
71.3
|
|
Combination therapy (Other ACT)
|
-
|
-
|
140
|
33.5
|
278
|
66.5
|
|
Monotherapy (Artemisinin based)
|
-
|
-
|
277
|
29.6
|
659
|
70.4
|
|
Monotherapy (Non-artemisinin)
|
-
|
-
|
106
|
40.8
|
154
|
59.2
|
- 1 % are row percentages within supercolumns
